Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
Canadian Agency for Drugs and Technologies in Health (CADTH)
Record ID 32015000824
English
Authors' recommendations:
Evidence from studies of limited quality suggests that dextrose prolotherapy for the management of musculoskeletal pain including low back pain, tendinopathy, and osteoarthritis may provide pain relief and improve physical function compared with saline injection control, exercise alone, or before prolotherapy treatment.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www.cadth.ca/prolotherapy-management-musculoskeletal-pain-review-clinical-effectiveness
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Tendinopathy
- Musculoskeletal Pain
- Musculoskeletal Diseases
- Osteoarthritis
- Injections, Intra-Articular
- Prolotherapy
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.